The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cheng Pan, Yukio Fujiwara, Hiromu Yano, Toshiki Anami, Yuki Ibe, Lianbo Li, Yuji Miura, Takanobu Motoshima, Shigeyuki Esumi, Junji Yatsuda, Taizo Hibi, Tomomi Kamba, Yoshihiro Komohara
Format: Artículo Open Access
Veröffentlicht: Wiley 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867016648521678848
author Cheng Pan
Yukio Fujiwara
Hiromu Yano
Toshiki Anami
Yuki Ibe
Lianbo Li
Yuji Miura
Takanobu Motoshima
Shigeyuki Esumi
Junji Yatsuda
Taizo Hibi
Tomomi Kamba
Yoshihiro Komohara
author_facet Cheng Pan
Yukio Fujiwara
Hiromu Yano
Toshiki Anami
Yuki Ibe
Lianbo Li
Yuji Miura
Takanobu Motoshima
Shigeyuki Esumi
Junji Yatsuda
Taizo Hibi
Tomomi Kamba
Yoshihiro Komohara
Cheng Pan
Yukio Fujiwara
Hiromu Yano
Toshiki Anami
Yuki Ibe
Lianbo Li
Yuji Miura
Takanobu Motoshima
Shigeyuki Esumi
Junji Yatsuda
Taizo Hibi
Tomomi Kamba
Yoshihiro Komohara
collection Wiley Open Access
contents The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages Cheng Pan Yukio Fujiwara Hiromu Yano Toshiki Anami Yuki Ibe Lianbo Li Yuji Miura Takanobu Motoshima Shigeyuki Esumi Junji Yatsuda Taizo Hibi Tomomi Kamba Yoshihiro Komohara Clinical & Translational Immunology AbstractObjectivesC‐reactive protein (CRP) is a well‐known acute‐phase protein that increases remarkably under various inflammatory conditions and is elevated in patients with malignant tumors. In this study, we investigated the influence of CRP on the tumor microenvironment in clear cell renal cell carcinoma (ccRCC).MethodsThis study explored CRP's role in ccRCC by co‐culturing human macrophages with ccRCC cells and employing antibody blocking, RNA sequencing and in vitro experiments for functional insights. We also analysed The Cancer Genome Atlas Program (TCGA) data to link CD64 expression with ccRCC prognosis and used immunohistochemistry to associate CD64+ macrophages with tumor severity and systemic CRP levels.ResultsA co‐culture study using human macrophages and RCC cell lines showed that CRP‐stimulated macrophages secrete IL‐6, which induces RCC proliferation via STAT3 activation. CRP‐induced protumor activation of macrophages was suppressed by CD64 blocking antibodies. Furthermore, CRP elevates PD‐L1 expression in macrophages via the CD64‐STAT1 signalling pathway. Statistical analysis of TCGA data indicated that increased CD64 expression was associated with a worse clinical course in ccRCC. Immunohistochemical analysis of pathological specimens revealed that high CD64 expression in tumor‐associated macrophages (TAMs), and a high density of CD64+ TAMs, was linked to high nuclear grade and stage. High CD64 expression was also correlated with increased serum CRP levels.ConclusionsThe CRP‐CD64 signal was linked to the protumor activation of TAMs and could be a promising target for anticancer immunotherapy in ccRCC. 10.1002/cti2.70013 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/cti2.70013
format Artículo Open Access
id wiley_oa_10_1002_cti2_70013
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages
Cheng Pan
Yukio Fujiwara
Hiromu Yano
Toshiki Anami
Yuki Ibe
Lianbo Li
Yuji Miura
Takanobu Motoshima
Shigeyuki Esumi
Junji Yatsuda
Taizo Hibi
Tomomi Kamba
Yoshihiro Komohara
Clinical & Translational Immunology
The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages Cheng Pan Yukio Fujiwara Hiromu Yano Toshiki Anami Yuki Ibe Lianbo Li Yuji Miura Takanobu Motoshima Shigeyuki Esumi Junji Yatsuda Taizo Hibi Tomomi Kamba Yoshihiro Komohara Clinical & Translational Immunology AbstractObjectivesC‐reactive protein (CRP) is a well‐known acute‐phase protein that increases remarkably under various inflammatory conditions and is elevated in patients with malignant tumors. In this study, we investigated the influence of CRP on the tumor microenvironment in clear cell renal cell carcinoma (ccRCC).MethodsThis study explored CRP's role in ccRCC by co‐culturing human macrophages with ccRCC cells and employing antibody blocking, RNA sequencing and in vitro experiments for functional insights. We also analysed The Cancer Genome Atlas Program (TCGA) data to link CD64 expression with ccRCC prognosis and used immunohistochemistry to associate CD64+ macrophages with tumor severity and systemic CRP levels.ResultsA co‐culture study using human macrophages and RCC cell lines showed that CRP‐stimulated macrophages secrete IL‐6, which induces RCC proliferation via STAT3 activation. CRP‐induced protumor activation of macrophages was suppressed by CD64 blocking antibodies. Furthermore, CRP elevates PD‐L1 expression in macrophages via the CD64‐STAT1 signalling pathway. Statistical analysis of TCGA data indicated that increased CD64 expression was associated with a worse clinical course in ccRCC. Immunohistochemical analysis of pathological specimens revealed that high CD64 expression in tumor‐associated macrophages (TAMs), and a high density of CD64+ TAMs, was linked to high nuclear grade and stage. High CD64 expression was also correlated with increased serum CRP levels.ConclusionsThe CRP‐CD64 signal was linked to the protumor activation of TAMs and could be a promising target for anticancer immunotherapy in ccRCC. 10.1002/cti2.70013 http://creativecommons.org/licenses/by/4.0/
title The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages
topic Clinical & Translational Immunology
url https://onlinelibrary.wiley.com/doi/10.1002/cti2.70013